May 26th, 2021
Targeted Cancer Therapies
ON THIS PAGE
What are targeted cancer therapies?
How are targets for targeted cancer therapies identified?
How are targeted therapies developed?
What types of targeted therapies are available?
…
Read ArticleMay 26th, 2021
Targeted Cancer Therapies
ON THIS PAGE
What are targeted cancer therapies?
How are targets for targeted cancer therapies identified?
How are targeted therapies developed?
What types of targeted therapies are available?
…
Read ArticleMay 25th, 2021
Check out the video hosted by Memorial Sloan Kettering entitled: Empowering Patients: Speak Up for Your Health. The link is listed below as well as the transcript.
The Empowered Patient: Speak Up for Your Health | Memorial Sloan Kettering Cancer…
Read ArticleMay 16th, 2021
SAN DIEGO, Nov. 11, 2020 /PRNewswire/ –InhibRx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in development, announced updated interim results today from a Phase 1 clinical trial evaluating the efficacy and safety of…
Read ArticleMay 8th, 2021
This coming Friday will be the Chondrosarcoma Foundation’s first anniversary. Last year, on May 14, 2020 during the beginning of the pandemic, we launched the Chondrosarcoma Foundation by bringing CS Foundation web site on-line. My…
Read ArticleMay 7th, 2021
November 13, 2020
Dylann Cohn-Emery
Treatment with the investigation agent INBRX-109 induced responses and decreased the tumor burden in a cohort of patients with chondrosarcoma, according to interim efficacy and safety findings a phase 1 trial in…
Read ArticleInhibrx Granted Fast Track Designation for INBRX-109 for the Treatment of Unresectable or Metastatic Conventional Chondrosarcoma Patients Registration-enabling study expected to begin dosing in the second or third quarter of this year
Read ArticleApril 30th, 2021
Elena Cojocaru,
Christopher Wilding,
Bodil Engelman,
Paul Huang &
Robin L. Jones
Current Molecular Biology Reports volume 6, pages1–9(2020)Cite this article
Is the IDH Mutation a Good Target for Chondrosarcoma Treatment? |…
Read ArticleAbstract
Dioxins are ubiquitous and persistent environmental contaminants whose background levels are still reason for concern. There is mounting evidence from both epidemiological and experimental studies that paternal exposure to the most potent…
Read ArticleSebastien passed away July 14, 2020 from dedifferentiated chondrosarcoma. This narrative was written and submitted by his sister Stephanie Desjardins.
In April 2019, my brother was diagnosed with a chondrosarcoma of chest wall on the right side…
Read ArticleApril 29th, 2021
Empowering Patients: Speak Up For Your Health
Tuesday, May 11, 2021 at 12:00 PM ET
Please consider registering to a special information session where our panel of experts will discuss the importance of advocating for patient care and treatment….
Read Article